Institution
Centre for Human Drug Research
Recent research
- Health & MedicineOpen access
A mechanism-based model of immune status effects on antibiotic PK/PD targets in bacteremia
Abstract A key determinant of antibiotic dose selection is the pharmacokinetic/pharmacodynamic (PK/PD) target, typically determined using dose fractionation studies in preclinical infection models. However, such studies often do not consider the host immune response, despite its...
- AI & ComputingOpen access
From Prediction to Decision Making: PBPK and QSP as Regulatory‐Grade NAMs
New approach methodologies (NAMs) encompass a diverse and rapidly evolving set of experimental and computational tools designed to generate human‐relevant mechanistic data for use in drug development and regulatory decision making. Experimental NAMs provide insights into drug dis...
- Health & MedicineOpen access
Immunosuppressed patients are susceptible to serious viral infections, often necessitating antiviral prophylaxis and/or treatment. Therapeutic drug monitoring (TDM) has been proposed to optimise drug exposure and clinical outcomes and is typically performed on full blood/plasma s...
- Society & EconomicsOpen access
Drug stock-outs in HIV, tuberculosis, and malaria programs: a systematic review
Background Stock-outs of antiretroviral, anti-tuberculosis, and anti-malarial medicines remain a major challenge in low- and middle-income countries, affecting both health systems and patient outcomes. This systematic review aimed to synthesize evidence on the causes, consequence...